홈 › 자궁내막암 › 펜실베이니아 › Philadelphia
PA Philadelphia의 자궁내막암 임상 시험
자궁내막암 관련 연구 28개가 Philadelphia 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
피험자 모집 중3상
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13마일 거리
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
피험자 모집 중2상
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- 외 4개
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
피험자 모집 중1상
- NRG Oncology, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, Philadelphia
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
피험자 모집 중2상
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · 8마일 거리
DESTINY-PANTUMOUR04
피험자 모집 중관찰 연구
- Research Site, Philadelphia
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
피험자 모집 중1상
- Research Site, Philadelphia
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
피험자 모집 중2상
- Thomas Jefferson University, Philadelphia
- Lankenau Medical Center, Wynnewood · 7마일 거리
- Asplundh Cancer Pavilion, Willow Grove · 13마일 거리
- 외 1개
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
피험자 모집 중1/2상
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
피험자 모집 중3상
- Hospital of the University of Pennsylvania ( Site 5007), Philadelphia
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
피험자 모집 중2상
- University of Pennsylvania, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
피험자 모집 중관찰 연구
- University of Pennsylvania, Philadelphia
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
피험자 모집 중3상
- Research Site, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
피험자 모집 중1상
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
피험자 모집 중1/2상
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
피험자 모집 중1상
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
피험자 모집 중1/2상
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
피험자 모집 중1상
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
피험자 모집 중1상
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
피험자 모집 중3상
- Research Site, Philadelphia
- Research Site, Willow Grove · 13마일 거리
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
피험자 모집 중1상
- Sidney Kimmel Cancer Center, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
피험자 모집 중초기 1상
- Abramson Cancer Center at Penn Medicine, Philadelphia
- University of Pennsylvania Gynecologic Oncology Department, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Philadelphia
다른 도시의 자궁내막암 시험
- Houston, TX연구 68개
- New York City, NY연구 52개
- Boston, MA연구 50개
- Arlington, VA연구 39개
- Nashville, TN연구 38개
- Los Angeles, CA연구 34개
- St. Louis, MO연구 29개
- San Antonio, TX연구 27개
- Columbus, OH연구 25개
- Oklahoma City, OK연구 25개
- Chicago, IL연구 25개
- Queens, NY연구 25개
Philadelphia의 다른 연구
- 암 (전체)연구 59개
- 유방암연구 56개
- 비소세포폐암연구 51개
- 전이성 암연구 46개
- 전립선암연구 44개
- 대장직장암연구 44개
- 난소암연구 44개
- 폐암연구 36개
- 급성 골수성 백혈병연구 34개
- 심부전연구 31개
- 우울증연구 26개
- 췌장암연구 26개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.